about
Unique role of dystroglycan in peripheral nerve myelination, nodal structure, and sodium channel stabilizationDistribution of dystroglycan in normal adult mouse tissuesDystroglycan is essential for early embryonic development: disruption of Reichert's membrane in Dag1-null miceDystroglycan binding to laminin alpha1LG4 module influences epithelial morphogenesis of salivary gland and lung in vitroZEB1 coordinately regulates laminin-332 and {beta}4 integrin expression altering the invasive phenotype of prostate cancer cellsrMATS: robust and flexible detection of differential alternative splicing from replicate RNA-Seq dataDisruption of perlecan binding and matrix assembly by post-translational or genetic disruption of dystroglycan function.Epithelial-to-mesenchymal transition in prostate cancer: paradigm or puzzle?Dystroglycan is not required for maintenance of the luminal epithelial basement membrane or cell polarity in the mouse prostate.Endothelin-1 inhibits prostate cancer growth in vivo through vasoconstriction of tumor-feeding arteriolesDystroglycan loss disrupts polarity and beta-casein induction in mammary epithelial cells by perturbing laminin anchoring.Assessing siRNA pharmacodynamics in a luciferase-expressing mouse.Resistance to fluid shear stress is a conserved biophysical property of malignant cells.A critical role of Gbetagamma in tumorigenesis and metastasis of breast cancer.Intestinal helminths regulate lethal acute graft-versus-host disease and preserve the graft-versus-tumor effect in mice.Prolyl-4-hydroxylase 3 (PHD3) expression is downregulated during epithelial-to-mesenchymal transition.Vinculin activators target integrins from within the cell to increase melanoma sensitivity to chemotherapy.An inducible model of abacterial prostatitis induces antigen specific inflammatory and proliferative changes in the murine prostate.Transcriptome-wide landscape of pre-mRNA alternative splicing associated with metastatic colonizationThe ARF tumor suppressor inhibits tumor cell colonization independent of p53 in a novel mouse model of pancreatic ductal adenocarcinoma metastasis.Loss of SOD3 (EcSOD) Expression Promotes an Aggressive Phenotype in Human Pancreatic Ductal Adenocarcinoma.Eradication of metastatic renal cell carcinoma after adenovirus-encoded TNF-related apoptosis-inducing ligand (TRAIL)/CpG immunotherapyDownregulation of dystroglycan glycosyltransferases LARGE2 and ISPD associate with increased mortality in clear cell renal cell carcinoma.The glycosyltransferase LARGE2 is repressed by Snail and ZEB1 in prostate cancer.Natural Products Discovered in a High-Throughput Screen Identified as Inhibitors of RGS17 and as Cytostatic and Cytotoxic Agents for Lung and Prostate Cancer Cell LinesLoss of LARGE2 disrupts functional glycosylation of α-dystroglycan in prostate cancer.CD151 promotes α3β1 integrin-dependent organization of carcinoma cell junctions and restrains collective cell invasionLoss of alpha-dystroglycan laminin binding in epithelium-derived cancers is caused by silencing of LARGE.Integrin α3β1 can function to promote spontaneous metastasis and lung colonization of invasive breast carcinoma.ZEB1 enhances transendothelial migration and represses the epithelial phenotype of prostate cancer cells.Individualization of Adjuvant Therapy After Radical Prostatectomy for Clinically Localized Prostate Cancer: Current Status and Future Directions.Alterations in cancer cell mechanical properties after fluid shear stress exposure: a micropipette aspiration study.α3β1 Integrin Suppresses Prostate Cancer Metastasis via Regulation of the Hippo Pathway.Down regulation of CSL activity inhibits cell proliferation in prostate and breast cancer cells.Bone-specific growth inhibition of prostate cancer metastasis by atrasentan.Targeting geranylgeranylation reduces adrenal gland tumor burden in a murine model of prostate cancer metastasisA Trp53fl/flPtenfl/fl mouse model of undifferentiated pleomorphic sarcoma mediated by adeno-Cre injection and in vivo bioluminescence imaging.Assessing tumor growth and distribution in a model of prostate cancer metastasis using bioluminescence imaging.Spiculated periosteal response induced by intraosseous injection of 22Rv1 prostate cancer cells resembles subset of bone metastases in prostate cancer patients.Dystroglycan: an extracellular matrix receptor linked to the cytoskeleton.
P50
Q28508732-8FF371E1-C1A5-47EF-8803-3C0F0C2F0E0EQ28590830-E0ACB66C-B3BA-4C69-8A89-A142C3B7C214Q28590908-86947715-19B4-44A6-BE7D-7FB60DD2A3B9Q28594567-926F6127-1793-4E58-8753-7EC5D8534A3DQ30497100-33EC91A3-3FF6-44CB-A44E-136A8E3D7E39Q30875027-DEA45ED4-6087-4AC4-95C0-A18F78A443B0Q33289428-8C141EA8-4052-46C8-8291-CD16E4FB3A61Q33351622-DCF779DD-D070-41A4-83F1-591832E91A2AQ33802362-515912D0-ED52-455B-AEEC-E2B1685A9547Q33873953-FD7D530A-DF62-4CBB-8587-843723A4DA71Q34377781-DF1E56E6-51A2-4552-B521-5CB24DC7C2A1Q34457509-0AFE0A09-271D-4C81-AAC8-C85B8D65AEABQ34506679-BA3C413F-C5DE-4CC9-8817-CBE5B41A2F0EQ34787134-D28C8931-AAB9-4B8A-8E5D-8233A0559076Q34980164-590418ED-D51C-4E08-99AD-A3F3F1B9DB96Q35075514-BDE3AF8B-A24F-4E86-9305-0F65EF8BAEF6Q35099507-81DEB594-400F-4508-8D8D-47DA70B508B7Q35106324-AD9A258C-326D-4108-B26E-6FF4ECD42D54Q35108922-87723320-3F8C-4EE6-BA44-F42B5D33A195Q35118952-FC5D1CC7-9414-4A35-8BB7-757E338EE534Q35251686-1216534A-0468-40C2-ACDA-22D6EBD222F2Q35721553-083EF670-B995-4547-B902-A92FC38EE9B9Q35899912-E7D3F6DD-F6DD-4D12-9D50-4FEE514D2B46Q36214643-2EE87000-40B3-4456-9139-CE6A93307FAAQ36407257-DDE09104-292E-4EBE-8A84-F338D1BF580BQ36561917-F19AA183-F892-43B4-B3BF-5EB10562D210Q36838910-DE935CCE-638A-4C6C-8513-AD85FC729255Q37160880-25C71D1A-0D9A-4D6C-89F1-7ACDF86251C1Q37625534-4FFA78B4-4FD1-4426-A131-58B67A3F938EQ38356519-C39D8AD8-1E20-41B2-A2D5-B2CA90B32A21Q38580951-E2079B99-2E85-4214-B6CB-739062BA4AFDQ39014529-99FE6483-46CB-409B-B396-8A82241A83C6Q39343833-A30C6927-CB45-46A7-A04F-5BEC211E3F1EQ39552827-E719A21D-58F6-4D01-AC41-CB7C6D9CDC41Q39742397-AD5866AB-2F78-4375-8F86-3B17CEA2DF61Q39830389-9FB150F7-42A0-4CF7-AD88-AC969AD41A37Q40070301-1C0AF522-7E51-4B7B-B782-C7356E3AFF42Q40279445-33AAB4CF-EA53-4CB7-9222-3B64296F1E78Q40395634-1A470F81-68BB-4EFB-B89B-8F27B460301DQ41238978-B7A1C44E-6C90-40A3-90C5-E5B3673FE95E
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Michael D Henry
@es
Michael D Henry
@nl
Michael D Henry
@sl
Michael D. Henry
@en
type
label
Michael D Henry
@es
Michael D Henry
@nl
Michael D Henry
@sl
Michael D. Henry
@en
prefLabel
Michael D Henry
@es
Michael D Henry
@nl
Michael D Henry
@sl
Michael D. Henry
@en
P106
P1153
7402290830
P31
P496
0000-0002-7871-245X